Wild, C. (2007): [Biosimilars]. HTA-Newsletter 54: p. 2.
Preview |
PDF (HTA-Newsletter 54)
- Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
354kB |
Official URL: http://hta.lbg.ac.at/de/newsletter_archive.php?iMenuID=63&iYear=2007
Item Type: | HTA Newsletter Item |
---|---|
Keywords: | Biosimilars, similar biological medical products, generics, generic medical products, biotechnology-derived proteins, comparison, approval |
Subjects: | QV Pharmacology, toxicology, pharmacy > QV 701-737 Pharmacy |
Related URLs: | http://hta.lbg.ac.at/en/content.php?iMenuID=40 |
References: | 1. EMEA/EU 2005: Guideline on similar biological medicinal products. URL: http://www.emea.eu.int/pdfs/human/biosimilar/043704en.pdf. 2. EMEA/EU 2006: Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance – quality issues. URL: http://www.emea.eu.int/pdfs/human/biosimilar/4283205en.pdf. 3. EMEA/EU 2006: Guideline on similar biological medicinal products containing biotechnology-derived proteins as. active substance containing biotechnology-derived proteins as active substance: non-clinical and clinical issues. URL: http://www.emea.eu.int/pdfs/human/biosimilar/4283205en.pdf. 4. Crommelin, D. et al. 2005: Pharmaceuticals of evaluation of biosimilars: important differences from generic low-molecular-weight pharmaceuticals, Eur J Hosp Pharmacy Science 11(1): 11. |
Language: | German |
Number: | 54 |
Deposited on: | 17 Jan 2008 19:50 |
Last Modified: | 15 Jul 2020 17:19 |
Repository Staff Only: item control page